Clinical Trials
Clinical Trials

Our Current Trials


A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa For FCX-007

This Phase 3 trial is recruiting. Learn more at ClinicalTrials.gov

 

A Phase 1/2 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

This Phase 1/2 trial is active, but not recruiting. Learn more at ClinicalTrials.gov

 

A Phase 1/2 Study of a Combination of FCX-013 (Genetically-Modified Autologous Human Dermal Fibroblasts) Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

This Phase 1/2 trial is currently recruiting adult patients. Learn more at ClinicalTrials.gov

 

A Multi-Center Study to Evaluate the Pharmacokinetics of Diacerein and Rhein and the Safety of Diacerein After Maximum Use, Topical Administration of CCP-020 (Diacerein 1% Ointment) to Patients With Epidermolysis Bullosa (EB)

Learn more at ClinicalTrials.gov